Nualtis Corp. Announces Participation in the 2026 Bloom Burton & Co. Healthcare Investor Conference
Montreal, Quebec--(Newsfile Corp. - April 20, 2026) - Nualtis Corp., a specialty pharmaceutical company focused on the development of innovative oral dissolvable film (ODF) drug delivery technologies, will be participating in the 2026 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 21 and 22 at the Metro Toronto Convention Centre.
Technologies, Biotechnologies, Services bancaires d’investissement, Santé
2026-04-20 11:41 AM EDT | Bloom Burton & Co. Inc.
LIS Technologies Inc. Announces Opening Keynote Presentation and Platinum Sponsorship of Reuters Events' SMR and Advanced Reactor 2026 Conference
Oak Ridge, Tennessee--(Newsfile Corp. - April 20, 2026) - LIS Technologies Inc. ("LIST" or "the Company"), a proprietary developer of advanced laser technology and the only USA-origin and patented laser uranium enrichment company, is pleased to announce its Platinum Sponsorship of the upcoming Reuters Events' SMR and Advanced Reactor 2026 Conference, Held in Austin, Texas on May 11-12, 2026. Christo Liebenberg, President and Co-Founder of LIS Technologies, will lead the event's D
Technologies, Mines et métaux, Énergie, Santé
2026-04-20 8:59 AM EDT | LIS Technologies Inc.
Orange Auto Insurance, Inc., Subsidiary of HPN Holdings, Inc. Announces Formation of its Strategic Advisory Board
Chicago, Illinois--(Newsfile Corp. - April 20, 2026) - HPN Holdings, Inc. (OTCID: KICK) ("HPN" or the "Company") today announced that its subsidiary Orange Auto Insurance, Inc ("Orange"), a managing general agency focused on delivering technology-driven automobile insurance solutions, today announced the formation of its Strategic Advisory Board, bringing together a group of experienced industry leaders to support the company's next phase of growth. The Advisory Board will provide guid
2026-04-20 8:55 AM EDT | HPN Holdings, Inc.
Numinus Wellness Responds to Trump Executive Order on Psychedelic Therapies
Vancouver, British Columbia--(Newsfile Corp. - April 20, 2026) - Numinus Wellness Inc. (OTC: NUMIF) today acknowledged the Executive Order signed by President Donald J. Trump directing United States federal agencies to accelerate research, access, and regulatory review for psychedelic-based treatments, including psilocybin, ibogaine, MDMA, and LSD. The Order directs the FDA to prioritize review of psychedelics with Breakthrough Therapy designation, establishes new investigational acces
2026-04-20 8:30 AM EDT | Numinus Wellness Inc.
Red Light Holland Highlights U.S. FDA-Authorized Study Supporting Multi-Session Psilocybin Therapy using Filament Health's Patented PEX010 Botanical Drug Candidate
Study conducted under U.S. FDA Investigational New Drug (IND) authorization by Dr. Anthony Back at the University of Washington Second psilocybin session showed meaningful improvements in anxiety, depression, and overall psychological outcomes, with effects lasting up to 24 weeks 69% of participants fell below clinical thresholds for anxiety and depression after second treatment Research builds on prior studies utilizing Filament's botanica
Cannabis, Santé, Psychédéliques, Fournisseurs de services auxiliaires liés au cannabis
2026-04-20 7:30 AM EDT | Red Light Holland Corp.
Yellowbird Diagnostics to Present at the Bloom Burton & Co. Healthcare Investor Conference
Toronto, Ontario--(Newsfile Corp. - April 20, 2026) - Yellowbird Diagnostics Inc. a clinical-stage biotechnology company developing next-generation metabolic imaging agents to detect disease earlier and guide clinical decision-making, today announced that it will participate in the Bloom Burton & Co. Healthcare Investor Conference taking place April 21-22, 2026, at the Metro Toronto Convention Centre in Toronto, Canada. Nick Calvert, Chief Executive Officer, and Michael Gottlieb, Ex
Technologies, Biotechnologies, Services bancaires d’investissement, Santé
2026-04-20 7:15 AM EDT | Bloom Burton & Co. Inc.
Rise Nano Optics Announces Strategic Partnership with Sierra Optical Lab to Produce and Commercialize SpectraGuard(TM) Lenses in the United States
Vancouver, British Columbia--(Newsfile Corp. - April 20, 2026) - Rise Nano Optics Ltd. (CSE: EYE) ("Rise" or the "Company"), a health technology company advancing vision care through patented nanotechnology lens solutions, today announced a strategic partnership with Sierra Optical Lab ("Sierra Optical"), an independent wholesale optical laboratory and VSP®-Authorized Lab, located in Reno, Nevada, to support the production and commercialization of its SPECTRAGUA
2026-04-20 7:00 AM EDT | Rise Nano Optics Ltd.
Optimi Health Launches Ibogaine Initiative as U.S. Executive Order Signals Pathway for Psychedelic Drug Products
Vancouver, British Columbia--(Newsfile Corp. - April 20, 2026) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) (the "Company" or "Optimi"), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today launched its Ibogaine Initiative, a program to extend the Company's Health Canada-licensed GMP platform to include the manufacture and supply of ibogaine. The initiative comes as the United States has, for the first time, taken ini
Biotechnologies, Pharmaceutique, Santé, Psychédéliques
2026-04-20 6:00 AM EDT | Optimi Health Corp.
Optimi Health startet Ibogaine-Initiative, da US-Executive Order einen Weg für psychedelische Arzneimittelprodukte signalisiert
Vancouver, British Columbia--(Newsfile Corp. - Montag, 20. April 2026) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) (das "Unternehmen" oder "Optimi"), ein kommerziell tätiger pharmazeutischer Hersteller regulierter psychedelischer Arzneimittelprodukte, gab heute den Start seiner Ibogaine-Initiative bekannt. Ziel des Programms ist es, die nach GMP lizenzierte Plattform des Unternehmens mit Health-Canada-Zulassung auf die Herstellung und Lieferung von Ibogaine auszuwe
Biotechnologies, Pharmaceutique, Santé, Psychédéliques
2026-04-20 2:00 AM EDT | Optimi Health Corp.
Northwyn Wellness Group Announces Participation in the 2026 Bloom Burton & Co. Healthcare Investor Conference
Vancouver, British Columbia--(Newsfile Corp. - April 19, 2026) - Northwyn Wellness Group, Canada's operator-led platform for medical aesthetics, dermatology, preventative medicine, and wellness clinics, will be participating in the 2026 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 21 and 22 at the Metro Toronto Convention Centre.
Technologies, Biotechnologies, Services bancaires d’investissement, Santé
2026-04-19 6:00 PM EDT | Bloom Burton & Co. Inc.
Unbuzzd Wellness Announces Resignation of Chief Executive Officer
Vancouver, British Columbia--(Newsfile Corp. - April 17, 2026) - Unbuzzd Wellness Inc. (the "Company" or "Unbuzzd"), the company behind unbuzzd™,the scientifically-proven beverage proven to accelerate alcohol metabolism, restore mental clarity, and reduce hangover symptoms, announces today that John Duffy has resigned from his position as Chief Executive Officer of the Company, effective as of the date hereof. The Company thanks Mr. Duffy for his contributions and wi
2026-04-17 5:00 PM EDT | Unbuzzd Wellness Inc.
Richards Group Inc. Announces Participation in The 2026 Bloom Burton & Co. Healthcare Investor Conference
Mississauga, Ontario--(Newsfile Corp. - April 17, 2026) - Richards Group Inc. (TSX: RIC) will be participating in the 2026 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 21 and 22 at the Metro Toronto Convention Centre.
Technologies, Biotechnologies, Services bancaires d’investissement, Santé
2026-04-17 1:32 PM EDT | Bloom Burton & Co. Inc.
All Star Health Brands (ALST) Explores Acquisition of Resort Property in Sanremo to Expand Future Soccer Programs
Toronto, Ontario--(Newsfile Corp. - April 17, 2026) - ALST (OTCID: ALST) today announced it is actively exploring the potential acquisition of a resort property in Sanremo, Italy, as part of a strategic initiative to expand its long-term investment in soccer development programs. The proposed acquisition reflects ALST's commitment to fostering athletic excellence, youth development, and international sports collaboration. The Sanremo location, known for its coastal setting and establish
Soins de santé et hôpitaux, Commerce de détail, Santé
2026-04-17 8:00 AM EDT | Allstar Health Brands, Inc.
Functional Brands Inc. Unveils New Weight Loss Support Bundle to Boost Digestion, Metabolism, and Muscle Preservation
Lake Oswego, Oregon--(Newsfile Corp. - April 17, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced the launch of its new Kirkman Weight Loss Support Bundle. Designed to support a healthy and sustainable weight loss journey, this bundle combines three scientifically-backed products to target key areas of digestion, metabolism, and muscle preservation. The Weight Loss Support Bundle includes:
Produits ménagers / de consommation / cosmétiques, Santé
2026-04-17 8:00 AM EDT | Functional Brands Inc.
Medexus Provides Business Update on GRAFAPEX (treosulfan) for Injection, Capital Allocation, and Investor Conference Participation
Ontario and Chicago, Illinois--(Newsfile Corp. - April 15, 2026) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) today provided an operational business update on the ongoing commercialization of GRAFAPEX™ (treosulfan) for Injection in the United States and on certain recent capital allocation and capital structure developments and announced company management's participation in two upcoming investor conferences. All dollar amounts in this news release are in US dollars unle
Biotechnologies, Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-04-15 5:30 PM EDT | Medexus Pharmaceuticals Inc.
Patient Safety Must Remain the Foundation of Scope of Practice Decisions in Canada
Ottawa, Ontario--(Newsfile Corp. - April 15, 2026) - As scope of practice expansion is actively being considered across Canada, the Canadian Ophthalmological Society (COS) is emphasizing that patient safety must remain the central and non-negotiable principle guiding any changes to healthcare delivery. While COS supports innovation and system modernization, it is deeply concerned that several proposed changes would expand independent clinical authority to non-physician providers without
Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-04-15 12:05 PM EDT | Canadian Ophthalmological Society (COS)
La sécurité des patients doit demeurer le fondement des décisions relatives au champ de pratique au Canada
Ottawa, Ontario--(Newsfile Corp. - 15 avril 2026) - Alors que l'élargissement des champs de pratique est activement envisagé à travers le Canada, la Société canadienne d'ophtalmologie (SCO) rappelle que la sécurité des patients doit demeurer le principe central et non négociable guidant toute évolution de la prestation des soins de santé. Bien que la SCO appuie l'innovation et la modernisation du système, elle demeure profondém
Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-04-15 12:05 PM EDT | Canadian Ophthalmological Society (COS)
Scryb Approves Proposed Name Change and Grant of Stock Options
Toronto, Ontario--(Newsfile Corp. - April 15, 2026) - Scryb Inc. (CSE: SCYB) ("Scryb'' or the "Company"), is pleased to announce that it intends to complete its corporate name change to NorthPalm Capital Corp., marking the next phase in the Company's evolution and reflecting a renewed strategic focus on shareholder value creation and disciplined growth. Under the new NorthPalm Capital, the Company plans to focus on timing, execution, and high-growth opportunities, suppo
Biotechnologies, Soins de santé et hôpitaux, Santé
2026-04-15 11:34 AM EDT | Scryb Inc.
Adia Nutrition, Inc. Announces Corporate Name Change to Adia Med, Inc. to Better Align with Its Regenerative Medicine and Biologics Business Model
Winter Park, Florida--(Newsfile Corp. - April 15, 2026) - Adia Nutrition, Inc. (OTCQB: ADIA), a publicly traded company focused on regenerative medicine, stem cell therapies, and biologic products, today announced that it is in the process of changing its corporate name to Adia Med, Inc. The name change reflects the company's evolving business model, which has shifted significantly toward advanced medical treatments and biologics. Adia now operates through key divisions inclu
Soins de santé et hôpitaux, Santé
2026-04-15 8:30 AM EDT | Adia Nutrition Inc.
FendX Engages Galenvs for Pilot Scale-Up Manufacturing of Its Liquid Surface Coating
Vancouver, British Columbia--(Newsfile Corp. - April 15, 2026) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company" or "FendX"), a technology company developing surface-protection solutions to reduce the spread of harmful pathogens, announces the signing of a statement of work ("SOW") dated April 14, 2026 with Galenvs Sciences Inc. ("Galenvs"), a Canadian contract manufacturing and service organization, to initiate pilot-scale manu
Technologies, Soins de santé et hôpitaux, Santé
2026-04-15 7:00 AM EDT | FendX Technologies Inc.